CD40L promotes development of acute aortic dissection via induction of inflammation and impairment of endothelial cell function
Related Experiment Video
Updated: Feb 13, 2026

A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation
Published on: December 9, 2021
Lu Han1,2,3,4,5, Lu Dai1,2,3,4,5, Yuan-Fei Zhao6
1Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Insights
Platelets' CD40 Ligand (CD40L) drives acute aortic dissection (AAD) by increasing inflammation and impairing endothelial cell function. Lowering CD40L may offer a new therapeutic strategy for this lethal cardiovascular disease.
Area of Science:
- Cardiovascular Research
- Immunology
- Vascular Biology
Background:
- Acute aortic dissection (AAD) is a life-threatening cardiovascular condition characterized by medial degradation.
- The precise mechanisms driving AAD pathogenesis remain incompletely understood.
- Platelet-derived CD40 Ligand (CD40L) is implicated in cardiovascular disease progression via pro-inflammatory pathways.
Observation:
- Serum CD40L levels are significantly elevated in human patients with AAD compared to healthy controls.
- Circulating CD40L concentrations are markedly increased in a mouse model of AAD induced by beta-aminopropionitrile (BAPN).
- AAD mice exhibit elevated levels of pro-inflammatory chemokines.
Findings:
- CD40L deficiency in mice (CD40L-/-) prevents the development of BAPN-induced AAD phenotypes.
- CD40L significantly inhibits endothelial cell migration, suggesting compromised vascular repair.
- Elevated CD40L correlates with increased inflammation and impaired endothelial function in AAD.
Implications:
- CD40L plays a critical role in promoting the development of acute aortic dissection.
- Targeting CD40L may represent a novel therapeutic approach for managing AAD.
- Understanding CD40L's pro-inflammatory and anti-migratory effects is key to preventing aortic dissection.
Abstract:
Acute aortic dissection is one of the most lethal cardiovascular disease. The major histopathological feature of AAD is medial degradation, especially breakdown of elastin and collagen. However, the underlying mechanism remains a mystery. Platelets expressed CD40 Ligand (CD40L) is recently recognised as a key effector of cardiovascular disease development through its pro-inflammatory effect. To clarify the role of CD40L in AAD, we examined level of CD40L in human blood serum samples and found that it is significantly higher in AAD patients compared with healthy subjects (26.8±5.52 ng/mL versus 13.4±4.00 ng/mL). To further investigate if CD40L is involve in the development of AAD, we applied β-aminopropionitrile (BAPN) induced mouse model of AAD. Consistent with the human data, circulating CD40L in AAD mice much higher than normal mice (148.40±75.96 pg/mL versus 44.09±19.65 pg/mL). Meanwhile, multiple pro-inflammatory chemokines significantly increased in AAD mice. Importantly, the CD40L-/- mice treated with BAPN did not develop these phenotypes. Lastly, we confirmed that endothelial cells migration was significantly inhibited by CD40L, suggesting impaired recovery from intimal injury. In summary, we found that CD40L promoted AAD development through its pro-inflammatory effects and inhibition of endothelial cell function.
Related Concept Videos
Inflammation
Fruit Development, Structure, and Function
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Induction
A...
Anaphase Promoting Complex

